Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

91 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Hormonal therapy in breast cancer].
Espinós J, Reyna C, de la Cruz S, Oiler C, Hernández A, Fernández Hidalgo O, Santisteban M, García Foncillas J. Espinós J, et al. Among authors: de la cruz s. Rev Med Univ Navarra. 2008 Jan-Mar;52(1):40-8. Rev Med Univ Navarra. 2008. PMID: 18578196 Review. Spanish.
Randomized crossover pharmacokinetic evaluation of subcutaneous versus intravenous granisetron in cancer patients treated with platinum-based chemotherapy.
Gurpide A, Sadaba B, Martin-Algarra S, Azanza JR, Lopez-Picazo JM, Campanero MA, Cabello JP, Gil-Aldea I, de la Cruz S, Fernandez Gallego V, Reyna C, Olier Garate C, Blanco-Prieto MJ, Ceballos J, Garcia-Foncillas J, Perez-Gracia JL. Gurpide A, et al. Among authors: de la cruz s. Oncologist. 2007 Sep;12(9):1151-5. doi: 10.1634/theoncologist.12-9-1151. Oncologist. 2007. PMID: 17914085 Free article. Clinical Trial.
Sequential administration of dose-dense epirubicin/cyclophosphamide followed by docetaxel/capecitabine for patients with HER2-negative and locally advanced or node-positive breast cancer.
Nieto Y, Aramendía JM, Espinós J, De la Cruz S, Fernández-Hidalgo O, Santisteban M, Arbea L, Aristu J, Martínez-Monge R, Moreno M, Pina L, Sola J, Zornoza G, Regueira FM. Nieto Y, et al. Among authors: de la cruz s. Cancer Chemother Pharmacol. 2010 Feb;65(3):457-65. doi: 10.1007/s00280-009-1049-y. Epub 2009 Jun 14. Cancer Chemother Pharmacol. 2010. PMID: 19526361 Free PMC article. Clinical Trial.
Modification of Breast Cancer Milieu with Chemotherapy plus Dendritic Cell Vaccine: An Approach to Select Best Therapeutic Strategies.
Mejías Sosa L, López-Janeiro Á, Córdoba Iturriagagoitia A, Sala P, Solans BP, Hato L, Inogés S, López-Díaz de Cerio A, Guillén-Grima F, Espinós J, De La Cruz S, Lozano MD, Idoate MA, Santisteban M. Mejías Sosa L, et al. Among authors: de la cruz s. Biomedicines. 2023 Jan 17;11(2):238. doi: 10.3390/biomedicines11020238. Biomedicines. 2023. PMID: 36830775 Free PMC article.
Adjuvant endocrine therapy in premenopausal women with breast cancer.
González Martín A, de la Cruz S, Márquez R. González Martín A, et al. Among authors: de la cruz s. Breast Cancer Res Treat. 2010 Sep;123 Suppl 1:43-7. doi: 10.1007/s10549-010-1045-2. Epub 2010 Aug 14. Breast Cancer Res Treat. 2010. PMID: 20711666 No abstract available.
Consensus of the Spanish society of laboratory medicine and the Spanish society of medical oncology on the methodology and criteria for evaluation of circulating tumour markers in breast cancer.
Ayala de la Peña F, Ortiz-Muñoz B, Quintanar-Verdúguez T, Santotoribio JD, de la Cruz S, Trapé-Pujol J, Galve-Calvo E, Augé-Fradera JM, García-Gómez J, González-Hernández Á. Ayala de la Peña F, et al. Among authors: de la cruz s. Clin Transl Oncol. 2021 Jul;23(7):1272-1280. doi: 10.1007/s12094-020-02529-x. Epub 2021 Feb 7. Clin Transl Oncol. 2021. PMID: 33550504 Free PMC article.
91 results